REQUEST E-APPLICATION FORM | 01244 746000 | Log in
Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.
Investments in unquoted companies carry high risks and investors could lose all funds invested. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. Investors are encouraged to take independent legal, tax and financial advice before considering an investment.
By clicking below, you confirm that you are an FCA authorised firm or individual and agree to be directed to our website, which is for FCA authorised firms and individuals only. Persons who do not meet this classification should leave this page.
If you are not a professional financial adviser, please contact the Deepbridge Investor Relations Team on 01244 746000 or by email at enquiries@deepbridgecapital.com.
We live in unprecedented times, with digitalisation and decoding of the human genome, combined with sufficient computational power, providing a fertile backdrop for medical innovation to aim to solve the biggest health problems facing the world in this century; including increasing and ageing population trends.
Growing companies require expert guidance and mentoring as well as adequate funding to stay focused on their strategies, exploit new opportunities and prepare for the next stage of development or exit. Investments will only be made in companies where Deepbridge either engages with or has vetted experienced professionals to work with the management team. Deepbridge will take board positions in all investee companies and takes an “active role” to guide, mentor and counsel the management team.
Through the combination of the high-quality investment management experience of the Deepbridge team, coupled with an opportunity to take advantage of the generous incentives offered through the current tax legislation, the opportunity to invest in the range of identified companies through the Deepbridge Technology Growth EIS is both timely and potentially compelling.
Andrew Hughes, Partner & Head of Renewables at Deepbridge Capital , answers some key questions regarding renewable energy.
Q. What makes renewable energy an interesting investment opportunity?
Deepbridge can confirm that the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS currently have capacity for deployment prior to 5 April 2019, as Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS funds are usually deployed on a monthly basis. The earlier your clients funds are invested, the greater the chance that they will be invested in the current tax year.
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
1. You could lose all the money you invest
2. You are unlikely to be protected if something goes wrong
3. You won’t get your money back quickly
4. Don’t put all your eggs in one basket
5. The value of your investment can be reduced
If you are interested in learning more about how to protect yourself, visit the FCA’s website here. [https://www.fca.org.uk/investsmart]
